Terumo: and Siemens Healthineers India collaborate to strengthen cardiac care in India

25 January 2023

  • Focus on joint healthcare training and education initiatives and innovative programs for physicians

  • The first of its kind Cathlab Director Program in India is being developed for physicians to increase efficiency and build standards of care

  • Hands-on training at Terumo India Skill Lab from basic to advanced programs and Siemens Healthineers’ robotics

Bengaluru – January 25, 2023 – Terumo and Siemens Healthineers India are partnering to strengthen cardiac care in India through collaborative interventions in medical education and development, access to advanced medical technologies and improved coverage in tier 2 and 3 cities. The collaboration will mark its efforts with a tailored training program for Cathlab professionals developed in collaboration with an eminent academic institute in India.

Currently, more structured courses are needed to increase operational efficiency and patient experience in Cathlabs. This first-of-its-kind Cathlab Director program will aim to meet this need and help raise the overall standards of care and efficiency in Cathlabs. The program will include topics on Operations Excellence, Digital Transformation and Patient Centricity.

“We are committed to advancing our mission of contributing to society through healthcare. Over the last four years, Terumo India has delivered numerous programs to HCPs on various topics related to interventional cardiology. We are pleased to partner with Siemens Healthineers on to strengthen the medical and clinical skills of Cathlab operators in India by providing advanced training in leadership, operational, strategic and technical skills.Through this collaboration, we want to make better cardiac care accessible to more people and thereby contribute to the changing landscape of a healthier India,” says Shishir Agarwal, MD of Terumo India.

“On our journey towards breakthrough healthcare, for everyone, everywhere, it is imperative to create platforms for collaborative growth. Through this industry-academia alliance, we aim to create holistic growth opportunities for specialized healthcare professionals. We are pleased to be a partner. with a globally trusted interventional medicine partner like Terumo and one of the reputed academic institutes in India to create an ecosystem to transform care delivery in India.” says Vivek Kanade, CEO, Siemens Healthcare Private Limited.

Other initiatives planned as part of the collaboration include training programs for interventional cardiologists and joint go-to-market initiatives for Tier 2 and 3 cities. Leveraging the respective strengths of both companies, hands-on training programs will be conducted at the Terumo India Skill Lab with cutting-edge medical technologies such as Siemens Healthineers’ robotics. In the future, the collaboration will be extended to educational programs and initiatives focusing on interventional radiologists.

About Terumo India

Terumo India is a fast-growing medical device company dedicated to promoting access to high-quality cardiovascular and other medical devices to patients and physicians in India. Terumo India is part of Terumo Corporation, a global leader in medical technology headquartered in Tokyo, Japan with over 28,000 employees worldwide. Established in 1921 and with its 100-year history, Terumo’s starting point and unchanging corporate mission has been ‘To contribute to society through healthcare.’

Terumo India was established in 2013 with headquarters in Gurgaon, NCR Delhi and has since grown to touch over 100,000 lives with an expanding field strength and distribution network. Terumo India is Great Place to Work® certified and has also been recognized as one of India’s Top 15 Workplaces™ in Pharmaceuticals, Healthcare and Biotechnology 2022. The company runs several recognized training and development programs in close collaboration with its clients and academic partners, to contribute to the skill requirements of India’s healthcare system.

For more information, visit www.terumoindia.com

About Siemens Healthineers AG

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is a pioneer in healthcare. To everyone. Everywhere. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers and its regional companies continuously develop their product and service portfolio with AI-enabled applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will strengthen the company’s foundation in in vitro diagnostics, image-guided therapy, in vivo diagnostics and innovative cancer treatment. Siemens Healthineers also provides a range of services and solutions to improve healthcare providers’ ability to deliver efficient, high-quality care. In fiscal 2022, which ended on September 30, 2022, Siemens Healthineers, which has approximately 69,500 employees worldwide, generated revenue of approximately €21.7 billion and adjusted EBIT of nearly €3.7 billion.

Further information is available at www.siemens-healthineers.com.

About Siemens Healthineers in India

Siemens Healthineers in India is Great Place to Work® certified with over 3,900 employees across the country. With a nationwide sales network and round-the-clock service setup, two manufacturing facilities in Vadodara for Diagnostics and in Bengaluru for medical imaging products, supported by a state-of-the-art R&D center as well as a global software development center in Bengaluru; we play a significant role in transforming the delivery of care in India, supporting healthcare providers across the entire spectrum of patient care – from prevention and early detection to diagnosis and beyond to treatment and aftercare. Further information is available at www.siemens-healthineers.co.in.

Disclaimer
Terumo Corporation published this content on 25 January 2023 and is solely responsible for the information therein. Distributed by Public, unedited and unaltered, the 25 Jan 2023 08:26:01 UTC.

Public now 2023

All news about TERUMO CORPORATION

Sale 2023 806 B
6 207 M
6 207 M
Net income 2023 98 283 M
757 m
757 m
Net debt 2023 9 138 M
70.3 m
70.3 m
P/E ratio 202328.8x
Dividend 20230.99%
Use of capital letters 2 765 B
21 286 M
21 286 M
EV / Sales 20233.44x
EV / Sales 20243.13x
Number of employees28 294
Free-Float96.8%

Chart TERUMO CORPORATION
Duration:

Period:

Terumo Corporation Technical Analysis Chart |  MarketScreener

Technical Analysis Trends TERUMO CORPORATION

Short termMidwayLong term
TrendsNeutralBearishNeutral

Development in the income statement

Sell

Buy

Average consensusBUY
Number of analysts14
Last closing price3,774.00 JPY
Average target price5,146.43 JPY
Spread / Average Measure36.4%

Terumo: and Siemens Healthineers India collaborate to strengthen cardiac care in India

Leave a Reply

Your email address will not be published.

Scroll to top